IL6 and hypertensive disorder: In seven patients who had comorbidities such as hypertension (14.3%), asthma (14.3%), and diabetes (14.3%), Ikram Zaid et al. [22] obtained statistically significant results in the reduction in inflammatory markers and acute phase reactants (IL-6 p-value = 0.0004, fibrinogen p-value = 0.015, ferritin p-value = 0.011, and PCR p-value = 0.06), and all seven patients survived [22].